Lipocine Inc. is a Delaware-incorporated biopharmaceutical company that leverages a proprietary lipid-based drug delivery technology platform to develop oral formulations of poorly bioavailable drugs. Its commercial product TLANDO (testosterone undecanoate) is FDA-approved for testosterone replacement therapy (TRT) and licensed to partners in the U.S., Canada, South Korea, GCC countries, and Brazil. Its pipeline includes CNS candidates for postpartum depression, major depressive disorder, essential tremor, and epilepsy.
expected 2026-12-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-10 | 2025-12-31 | 0001493152-26-009411 | EDGAR | 69K words |
| 2025-03-13 | 2024-12-31 | 0001493152-25-010146 | EDGAR | 72K words |
| 2024-03-07 | 2023-12-31 | 0001493152-24-009127 | EDGAR | 74K words |
| 2023-03-10 | 2022-12-31 | 0001493152-23-007178 | EDGAR | — |
| 2022-03-09 | 2021-12-31 | 0001493152-22-006353 | EDGAR | — |
| 2021-03-11 | 2020-12-31 | 0001104659-21-034761 | EDGAR | — |
| 2020-03-13 | 2019-12-31 | 0001104659-20-032764 | EDGAR | — |
| 2019-03-06 | 2018-12-31 | 0001144204-19-012434 | EDGAR | — |
| 2018-03-12 | 2017-12-31 | 0001144204-18-013981 | EDGAR | — |
| 2017-03-06 | 2016-12-31 | 0001144204-17-012930 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-04 | 2026-06-30 | 0001493152-26-035909 | EDGAR | 32K words |
| 2025-11-06 | 2025-09-30 | 0001493152-25-021007 | EDGAR | 32K words |
| 2025-08-05 | 2025-06-30 | 0001493152-25-011588 | EDGAR | 34K words |
| 2025-05-08 | 2025-03-31 | 0001641172-25-009180 | EDGAR | 30K words |
| 2024-11-07 | 2024-09-30 | 0001493152-24-043893 | EDGAR | 36K words |
| 2024-08-08 | 2024-06-30 | 0001493152-24-030648 | EDGAR | 35K words |
| 2024-05-09 | 2024-03-31 | 0001493152-24-018311 | EDGAR | 31K words |
| 2023-11-08 | 2023-09-30 | 0001493152-23-039861 | EDGAR | 39K words |
| 2023-08-10 | 2023-06-30 | 0001493152-23-027460 | EDGAR | 36K words |
| 2023-05-11 | 2023-03-31 | 0001493152-23-016293 | EDGAR | 31K words |
| 2022-11-09 | 2022-09-30 | 0001493152-22-031032 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0001493152-22-021567 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-16 | 0001493152-26-042933 | EDGAR | 0K words |
| 2026-09-14 | 0001493152-26-042466 | EDGAR | 2K words |
| 2026-09-11 | 0001493152-26-042286 | EDGAR | 0K words |
| 2026-09-10 | 0001493152-26-042052 | EDGAR | 1K words |
| 2026-08-04 | 0001493152-26-035913 | EDGAR | 3K words |
| 2026-08-03 | 0001493152-26-035762 | EDGAR | 1K words |
| 2026-04-02 | 0001493152-26-014835 | EDGAR | 1K words |
| 2026-04-02 | 0001493152-26-014834 | EDGAR | 1K words |
| 2026-03-10 | 0001493152-26-009428 | EDGAR | 3K words |
| 2026-03-04 | 0001493152-26-008852 | EDGAR | 1K words |
524 total filings indexed. 492 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001535955 |
| Ticker | LPCN |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.lipocine.com |
| Listed | 2012-06-05 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/LPCN (~200 tokens, structured JSON with cryptographic provenance)